Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands

Bertini, Simone; Chicca, Andrea; Arena, Chiara; Chicca, Stefano; Saccomanni, Giuseppe; Gertsch, Jürg; Manera, Clementina; Macchia, Marco (2016). Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands. European journal of medicinal chemistry, 116, pp. 252-266. Elsevier Masson SAS 10.1016/j.ejmech.2016.03.072

[img] Text
Bertini_EurJMedChem_2016.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Targeting type-2 cannabinoid receptor (CB2) is considered a feasible strategy to develop new drugs for the treatment of diseases like neuropathic pain, chronic inflammation, neurodegenerative disorders and cancer. Such drugs are devoid of the undesired central side effects that are typically mediated by the CB1 receptor. In this work we synthesized 18 biphenylic carboxamides as new CB2-selective ligands and evaluated their pharmacological profiles. The functional activity of these compounds is strongly influenced by the nature of the substituent at position 4' and 5 of the biphenyl scaffold. Position 5 seems to be responsible for the agonist or inverse agonist behaviour independently of the substituent in position 4', with the exception of the methoxyl group which transforms both full agonists and inverse agonists into neutral antagonists. This study provides a novel complete toolbox of CB2 functional modulators that derive from the same chemical scaffold. Such probes may be useful to investigate the biological role of CB2 receptors in cellular assays.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Other Institutions > NCCR TransCure
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Biochemistry and Molecular Medicine

UniBE Contributor:

Chicca, Andrea; Arena, Chiara and Gertsch, Jürg

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0223-5234

Publisher:

Elsevier Masson SAS

Language:

English

Submitter:

Valentina Rossetti

Date Deposited:

15 Sep 2016 11:25

Last Modified:

15 Sep 2016 11:25

Publisher DOI:

10.1016/j.ejmech.2016.03.072

PubMed ID:

27078864

Uncontrolled Keywords:

Biphenyl-carboxamides; CB(2); CB(2) agonist; CB(2) antagonist; CB(2) inverse agonist; Cannabinoid receptor; Endocannabinoid system; Methylhonokiol

BORIS DOI:

10.7892/boris.87533

URI:

https://boris.unibe.ch/id/eprint/87533

Actions (login required)

Edit item Edit item
Provide Feedback